EUROFINS SCIENTIFIC SE | WebDisclosure

Switch to English

8610	Sociétés
141678	Mots-clés
77590	Articles
75719	Communiqués

Accueil
Sociétés
EUROFINS SCIENTIFIC SE

COMMUNIQUÉ DE PRESSE

publié le 19/03/2025 à 20:29, il y a 22 jours 21 heures

Acquisition or disposal of the issuer's own shares / Description of the buyback program
Eurofins Scientific SE announces its fifth buy-back programme of own shares, aiming to repurchase up to 4.5% of share capital. Programme starts on 20 March 2025

Share Capital Investor Relations Own Shares Buy-back Programme Eurofins
BRÈVE

publiée le 26/02/2025 à 07:52, il y a 1 mois 13 jours

Eurofins publie son rapport annuel 2024

États Financiers Rapport Annuel Bourse De Luxembourg Eurofins Bio-analyse
BRÈVE

publiée le 26/02/2025 à 07:52, il y a 1 mois 13 jours

Eurofins Publishes 2024 Annual Report

Financial Statements Annual Report Luxembourg Stock Exchange Eurofins Bio-analysis
COMMUNIQUÉ DE PRESSE

publié le 26/02/2025 à 07:47, il y a 1 mois 13 jours

Annual financial and audit reports / Terms of availability of the annual financial report
Eurofins releases its 2024 Annual Report, including Management, Remuneration, and Corporate Governance Reports. Available on Eurofins website. Contact Investor Relations for more info

Financial Statements Investor Relations Corporate Governance Eurofins 2024 Annual Report
BRÈVE

publiée le 19/02/2025 à 17:52, il y a 1 mois 20 jours

EUROFINS SCIENTIFIC SE met à jour la divulgation des droits de vote

Structure Du Capital Divulgation Financière Informations Pour Les Actionnaires Eurofins Scientific SE Mise À Jour Sur Les Droits De Vote
BRÈVE

publiée le 19/02/2025 à 17:52, il y a 1 mois 20 jours

EUROFINS SCIENTIFIC SE Updates Voting Rights Disclosure

Shareholder Information Financial Disclosure Capital Structure Eurofins Scientific SE Voting Rights Update
COMMUNIQUÉ DE PRESSE

publié le 19/02/2025 à 17:47, il y a 1 mois 20 jours

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Disclosure of updated total number of voting rights and capital by EUROFINS SCIENTIFIC SE on 31 January 2025 in compliance with transparency regulations

Share Capital Voting Rights Update Transparency Regulations Eurofins Scientific SE
BRÈVE

publiée le 20/12/2024 à 18:30, il y a 3 mois 21 jours

Eurofins Scientific lance son quatrième programme de rachat d'actions

Rachat D'actions Stratégie D'investissement Services Financiers Eurofins Conditions Du Marché
BRÈVE

publiée le 20/12/2024 à 18:30, il y a 3 mois 21 jours

Eurofins Scientific Initiates Fourth Share Buyback Program

Share Buyback Investment Strategy Financial Services Market Conditions Eurofins
COMMUNIQUÉ DE PRESSE

publié le 20/12/2024 à 18:25, il y a 3 mois 21 jours

Acquisition or disposal of the issuer's own shares / Description of the buyback program
Eurofins Scientific SE announces the launch of its fourth buy-back programme of own shares, aiming to repurchase up to 2% of its share capital. The company may use the shares for various purposes approved by the Board of Directors

Investment Strategy Financial Services Buy-back Programme Eurofins Scientific SE Shares Repurchase

Les Echos

Publié le 11/04/2025 à 17:50, il y a 9 minutes

Mise à disposition du Rapport Financier Annuel 2024
Publié le 11/04/2025 à 17:45, il y a 15 minutes

NFL Biosciences présente ses résultats annuels 2024 et fait le point sur son programme clinique
Publié le 11/04/2025 à 17:45, il y a 15 minutes

NFL Biosciences presents its 2024 annual results and provides an update on its clinical program
Publié le 11/04/2025 à 17:45, il y a 15 minutes

STEF : Droits de vote au 31-03-2025
Publié le 11/04/2025 à 13:49, il y a 4 heures 10 minutes

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 mars 2025

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 11/04/2025 à 15:00, il y a 3 heures

Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy
Publié le 11/04/2025 à 15:00, il y a 3 heures

Bullfrog AI and Connect Biopharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Publié le 11/04/2025 à 14:30, il y a 3 heures 30 minutes

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
Publié le 11/04/2025 à 14:00, il y a 4 heures

Greta Van Susteren Signs Multi-Year Renewal with Newsmax
Publié le 11/04/2025 à 14:00, il y a 4 heures

APPULSE CORPORATION (Listed on the TSX Venture Exchange - Symbol 'APL') Press Release - Reporting Results for the 2024 Fiscal Year

Voir tout ACCESSWIRE

EQS Group

Publié le 11/04/2025 à 17:40, il y a 20 minutes

INFICON to Publish its Results for the First Quarter of 2025 on Thursday, April 24, 2025
Publié le 11/04/2025 à 17:40, il y a 20 minutes

Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25
Publié le 11/04/2025 à 17:07, il y a 52 minutes

EQS-Adhoc: Delivery Hero increases provisions for legal risks following delivery riders reclassification decision in Italy and updates preliminary adjusted EBITDA for FY 2024
Publié le 11/04/2025 à 16:30, il y a 1 heure 30 minutes

Northern Data AG – Invitation to Annual General Meeting on 21 May 2025
Publié le 11/04/2025 à 16:15, il y a 1 heure 45 minutes

SoftwareOne announces extension of the offer period in the recommended voluntary share and cash offer for Crayon